Lucid Diagnostics Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.076 million compared to USD 0.2 million a year ago. Net loss was USD 14.35 million compared to USD 6.96 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to USD 0.49 a year ago.
For the nine months, sales was USD 0.265 million compared to USD 0.2 million a year ago. Net loss was USD 41.24 million compared to USD 16.77 million a year ago. Basic loss per share from continuing operations was USD 1.15 compared to USD 1.19 a year ago.